News

News

PHI and BioSpherix expand marketing partnership after scientific evaluation

In June 2018, Phase Holographic Imaging (PHI) and BioSpherix Medical entered a collaboration agreement, aiming to co-market the companies’ complementary product lines. BioSpherix develops and market advanced hermetically sealed cell incubators for the control and optimization of cell culture environments.

Read more

Cancer researchers use HoloMonitor to track skin cancer cells

Scientists at the Holographic Imaging Cytometry Center of Excellence at University of California, San Francisco, study how normal skin cells transform into aggressive skin cancer. HoloMonitor M4 plays an important role in their research. Read more about their work here.

Read more

Single Cell Tracking for early Skin Cancer Detection

Melanoma, the most dangerous form of skin cancer, is increasing. In the US, melanoma is one of the most common cancers among young adults. However, if the disease is caught early, then it can be cured. A research team, led by Dr Robert Judson-Torres, is tracking single cells when studying melanoma at an early stage.

Read more

Replacing animal experiments with advanced cell culture studies

Tests on animals are routinely used in many research areas, including pre-clinical drug development and testing of chemicals and cosmetics. Today, there is a growing interest in developing alternatives to research methods that involves living animals, and also to replace animal derived components used in different kind of products.

Read more

New Publication shows Advantages of using HoloMonitor® for Cell Movement Assessment

Understanding of cell movements is essential in many aspects of cell biology research, and crucial not least in cancer research. Cell movements have a key role both when it comes to exploring how unharmful cells transform into dangerous cancer cells, and in the search for new therapeutic strategies based on the human body´s own defense

Read more

Interim Report for the second quarter

For the first time, sales during the past 12 months reached 5 MSEK. Since our previous report, much effort has gone into implementing the ambitious market expansion made possible by the capital acquisition this summer.

Read more

Lunds Universitet och PHI samarbetar kring utveckling av nya 3D-cellodlingsmetoder för immunterapiforskning

Baserat på PHI:s befintliga HoloMonitor-teknik, har institutionen för Immun­teknologi vid Lunds Universitet och Phase Holographic Imaging (PHI) avtalat om att gemensamt utveckla nya metoder för 3‑dimensionell cell­odling. Detta för att möta ett akut och snabbt växande behov av dessa metoder inom cancerforskningen.

Read more

Lund University and PHI partner to develop novel 3D cell culturing methods for immunotherapy research

Based on PHI’s current HoloMonitor technology, the Department of Immunotechnology at Lund University and Phase Holographic Imaging (PHI) recently agreed to jointly develop novel 3-dimensional cell culturing methods to meet the urgent need for such methods.

Read more

A study of cancer cells by digital holographic imaging, fluorescence and a combination thereof

Digital holographic imaging is a label-free, non-toxic quantitative method that can be used for single cell analysis for a long time period. Sofia Kamlund, PhD, Lund University and Phase Holographic Imaging, has used this method in her thesis Not all those who wander are lost – A Study of Cancer Cells by Digital Holographic Imaging, Fluorescence and a combination there of. The technique allows the researcher to follow changes over time and evaluate cell response on living cells.

Read more

Dissertation: A study of Cancer Cells by Digital Holographic Imaging

Sofia Kamlund has studied Cell Division and Cell Movement using Digital Holographic Microscopy. Her research presents new ways of analyzing individual cells by using Holographic Microscopy alone or in combination with Fluorescence Microscopy.

Read more